Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 139-144

  Weigle, Bernd ^a   Ebner, Reinhard ^b   Temme, Achim ^a   Schwind, Sandra ^a   Schmitz, Marc ^a   Kiessling, Andrea ^a   Rieger, Michael A ^a   Schackert, Gabriele ^a   Schackert, Hans K ^a   Rieber, E Peter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Avalon Pharmaceuticals   (United States)

Author keywords

Glioblastoma multiforme; Glioma overexpressed gene; Quantitative RT PCR

Indexed keywords

DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; SOX11 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU;

ARTICLE; BRAIN TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; TRANSACTIVATION;

BRAIN NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNOTHERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POU DOMAIN FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 21644455363     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.139     Document Type: Article

References (38)

1. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS and Linet MS: Cancer surveillance series: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91: 1382-1390, 1999. (Pubitemid 29399996)
2. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001. (Pubitemid 32524640)
3. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP and Bronstein JM: Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90: 1115-1124, 1999. (Pubitemid 29241181)
4. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM and Black KL: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61: 842-847, 2001. (Pubitemid 32175145)
5. Reardon DA, Akabani G, Coleman RE, et al: Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J Clin Oncol 20:1389-1397, 2002. (Pubitemid 34177447)
6. Yamanaka R, Abe T, Yajima N, Tsuchiya N, Homma J, Kobayashi T, Narita M, Takahashi M and Tanaka R: Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer 89: 1172-1179, 2003. (Pubitemid 37363398)
7. Marras C, Mendola C, Legnani FG and DiMeco F: Immunotherapy and biological modifiers for the treatment of malignant brain tumors. Curr Opin Oncol 15: 204-208, 2003. (Pubitemid 36735173)
8. Behrends U, Jandl T, Golbeck A, Lechner B, Muller-Weihrich S, Schmid I, Till H, Berthold F, Voltz R and Mautner JM: Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library. Int J Cancer 100: 669-677, 2002. (Pubitemid 34832976)
9. Banchereau J, Palucka AK, Dhodapkar M, et al: Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 61: 6451-6458, 2001. (Pubitemid 32783251)
10. Yamanaka R, Yajima N, Abe T, Tsuchiya N, Homma J, Narita M, Takahashi M and Tanaka R: Dendritic cell-based glioma immunotherapy (review). Int J Oncol 23: 5-15, 2003.
11. Shen-Ong GL, Feng Y and Troyer DA: Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology. Cancer Res 63: 3296-3301, 2003. (Pubitemid 36735886)
12. Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27: 1409-1420, 1999.
13. Liu Y, Ng KY and Lillehei KO: Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma. Cancer Control 10: 138-147, 2003. (Pubitemid 36437820)
14. Goetz C, Riva P, Poepperl G, Gildehaus FJ, Hischa A, Tatsch K and Reulen HJ: Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times. J NeuroOncol 62: 321-328, 2003. (Pubitemid 36591969)
15. Baselga J: Targeting the epidermal growth factor receptor: a clinical reality. J Clin Oncol 19 (Suppl 18): 41S-44S, 2001.
16. Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL and Hoon DS: Molecular detection of tumorassociated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150: 2143-2152, 1997. (Pubitemid 27233085)
17. Debinski W, Gibo DM and Puri RK: Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13. Int J Cancer 76: 547-551, 1998. (Pubitemid 28227999)
18. Scarcella DL, Chow CW, Gonzales MF, Economou C, Brasseur F and Ashley DM: Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. Clin Cancer Res 5: 335-341, 1999. (Pubitemid 29085187)
19. Sasaki M, Nakahira K, Kawano Y, Katakura H, Yoshimine T, Shimizu K, Kim SU and Ikenaka K: MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma. Cancer Res 61: 4809-4814, 2001. (Pubitemid 32691895)
20. Imaizumi T, Kuramoto T, Matsunaga K, Shichijo S, Yutani S, Shigemori M, Oizumi K and Itoh K: Expression of the tumorrejection antigen SART1 in brain tumors. Int J Cancer 83: 760-764, 1999.
21. Murayama K, Kobayashi T, Imaizumi T, Matsunaga K, Kuramoto T, Shigemori M, Shichijo S and Itoh K: Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides. J Immunother 23:511-518,2000.
22. Sahin U, Koslowski M, Tureci O, Eberle T, Zwick C, Romeike B, Moringlane JR, Schwechheimer K, Feiden W and Pfreundschuh M: Expression of cancer testis genes in human brain tumors. Clin Cancer Res 6: 3916-3922, 2000.
23. Jungbluth AA, Stockert E, Huang HJ, et al: A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci USA 100: 639-644, 2003. (Pubitemid 36126105)
24. Sonoda Y, Kanamori M, Deen DF, Cheng SY, Berger MS and Pieper RO: Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis. Cancer Res 63: 1962-1968, 2003. (Pubitemid 36460864)
25. Van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G and Hanash SM: Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163: 1033-1043, 2003. (Pubitemid 37040139)
26. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF and Nelson SF: Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22: 2361-2373, 2003. (Pubitemid 36566791)
27. Uwanogho D, Rex M, Cartwright EJ, Pearl G, Healy C, Scotting PJ and Sharpe PT: Embryonic expression of the chicken Sox2, Sox3 and Sox 11 genes suggests an interactive role in neuronal development. Mech Dev 49: 23-36, 1995.
28. Jay P, Goze C, Marsollier C, Taviaux S, Hardelin JP, Koopman P and Berta P: The human SOXll gene: cloning, chromosomal assignment and tissue expression. Genomics 29: 541-545, 1995.
29. Hargrave M, Wright E, Kun J, Emery J, Cooper L and Koopman P: Expression of the Soxl 1 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction Dev Dyn 210: 79-86, 1997. (Pubitemid 27424253)
30. Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I and Wegner M: Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem 273: 16050-16057, 1998. (Pubitemid 28311373)
31. Lee CJ, Appleby VJ, Orme AT, Chan WI and Scotting PJ: Differential expression of SOX4 and SOX11 in medulloblastoma J Neurooncol 57: 201-214, 2002. (Pubitemid 34692628)
32. Wiebe MS, Nowling TK and Rizzino A: Identification of novel domains within Sox-2 and Sox-11 involved in autoinhibition of DNA binding and partnership specificity. J Biol Chem 278' 17901-17911,2003.
33. Tani M, Shindo-Okada N, Hashimoto Y, Shiroishi T, Takenoshita S, Nagamachi Y and Yokota J: Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells. Genomics 39: 30-37, 1997. (Pubitemid 27057269)
34. Xia Y, Papalopulu N, Vogt PK and Li J: The oncogenic potential of the high mobility group box protein Sox3. Cancer Res 60: 6303-6306, 2000.
35. McGowan EM and Clarke CL: Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Mol Endocrinol 13: 1657-1671 1999. (Pubitemid 30645271)
36. Ahn SG, Cho GH, Jeong SY, Rhim H, Choi JY and Kim IK: Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/deltaI2-PGJ2 in Hep3B cells. Biochem Biophys Res Commun 260: 216-221, 1999. (Pubitemid 29351810)
37. McCracken S, Kim CS, Xu Y, Minden M and Miyamoto NG: An alternative pathway for expression of p561ck from type I promoter transcripts in colon carcinoma. Oncogene 15: 2929-2937 1997. (Pubitemid 28008985)
38. Rammensee H, Bachmann J, Emmerich NP, Bachor OA and Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219, 1999. (Pubitemid 30099526)